Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-074423
Filing Date
2015-10-06
Accepted
2015-10-06 18:45:01
Documents
1
Period of Report
2015-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 15965
  Complete submission text file 0001209191-15-074423.txt   18588
Mailing Address 575 HIGH STREET, SUITE 201 PALO ALTO CA 94301
Business Address 575 HIGH STREET, SUITE 201 PALO ALTO CA 94301 (650) 688-0818
Vivo Ventures Fund VII, L.P. (Reporting) CIK: 0001509160 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37581 | Film No.: 151147459

Mailing Address 575 HIGH STREET, SUITE 201 PALO ALTO CA 94301
Business Address 575 HIGH STREET, SUITE 201 PALO ALTO CA 94301 (650) 688-0818
Vivo Ventures VII Affiliates Fund, L.P. (Reporting) CIK: 0001538309 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37581 | Film No.: 151147458

Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 575 HIGH STREET #201 PALO ALTO CA 94301
Business Address 575 HIGH STREET #201 PALO ALTO CA 94301 (650) 688-0818
VIVO VENTURES VII, LLC (Reporting) CIK: 0001565020 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-37581 | Film No.: 151147460